Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconverters

Journal of Gastroenterology and Hepatology (Australia)

Volumn 29, Issue 6, 2014, Pages 1242-1249

  Tseng, Tai Chung ^a,d   Liu, Chun Jen ^b,c   Yang, Wan Ting ^c   Chen, Chi Ling ^c   Yang, Hung Chih ^b,c   Su, Tung Hung ^b,c   Wang, Chia Chi ^a,d   Kuo, Stephanie Fang Tzu ^e   Liu, Chen Hua ^b,c   Chen, Pei Jer ^b,c   Chen, Ding Shinn ^b,c   Kao, Jia Horng ^b,c  

^a TAIPEI TZU CHI HOSPITAL   (Taiwan)

^b Division of Gastroenterology   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d TZU CHI UNIVERSITY   (Taiwan)

^e ST VINCENT S HOSPITAL   (Australia)

Author keywords

Chronic hepatitis B; HbeAg; HbsAg; Liver disease; SEARCH B; Viral replication

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; VIRUS DNA; BIOLOGICAL MARKER;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SEROCONVERSION; TAIWAN; VIRUS LOAD; VIRUS REACTIVATION; VIRUS REPLICATION; BLOOD; COHORT ANALYSIS; DISEASE COURSE; GENETICS; IMMUNOLOGY; PHYSIOLOGY; SEROLOGY; TIME; VIROLOGY; VIRUS ACTIVATION;

ADULT; BIOLOGICAL MARKERS; COHORT STUDIES; DISEASE PROGRESSION; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; MALE; RETROSPECTIVE STUDIES; SEROLOGIC TESTS; TIME FACTORS; VIRAL LOAD; VIRUS ACTIVATION; VIRUS REPLICATION;

EID: 84900549965     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12502     Document Type: Article

References (27)

1. Chen DS. From hepatitis to hepatoma: lessons from type B viral hepatitis. Science 1993; 262: 369-370.
2. Kao JH. Hepatitis B virus genotypes and hepatocellular carcinoma in Taiwan. Intervirology 2003; 46: 400-407.
3. Liaw YF, Chu CM. Hepatitis B virus infection. Lancet 2009; 373: 582-592.
4. Liaw YF, Lau GK, Kao JH, Gane E. Hepatitis B e antigen seroconversion: a critical event in chronic hepatitis B virus infection. Dig. Dis. Sci. 2010; 55: 2727-2734.
5. Hsu YS, Chien RN, Yeh CT etal. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology 2002; 35: 1522-1527.
6. Chu CM, Liaw YF. Predictive factors for reactivation of hepatitis B following hepatitis B e antigen seroconversion in chronic hepatitis B. Gastroenterology 2007; 133: 1458-1465.
7. Tai DI, Lin SM, Sheen IS, Chu CM, Lin DY, Liaw YF. Long-term outcome of hepatitis B e antigen-negative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time. Hepatology 2009; 49: 1859-1867.
8. Chu CM, Hung SJ, Lin J, Tai DI, Liaw YF. Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum aminotransferase levels. Am. J. Med. 2004; 116: 829-834.
9. Tseng TC, Liu CJ, Chen CL etal. Serum hepatitis B virus-DNA levels correlate with long-term adverse outcomes in spontaneous hepatitis B e antigen seroconverters. J. Infect. Dis. 2012; 205: 54-63.
10. Tseng TC, Kao JH. Clinical utility of quantitative HBsAg in natural history and nucleos(t)ide analogue treatment of chronic hepatitis B: new trick of old dog. J. Gastroenterol. 2013; 48: 13-21.
11. Chen CJ, Yang HI, Su J etal. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006; 295: 65-73.
12. Tseng TC, Liu CJ, Yang HC etal. High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load. Gastroenterology 2012; 142: 1140-1193; quiz e13-4.
13. Tseng TC, Liu CJ, Yang HC etal. Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads. Hepatology 2013; 57: 441-450.
14. Tseng TC, Liu CJ, Su TH etal. Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters. Gastroenterology 2011; 141: 517-25 e2.
15. Liaw YF, Kao JH, Piratvisuth T etal. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update. Hepatol. Int. 2012; 6: 531-561.
16. European Association for the Study of the L. EASL Clinical Practice Guidelines: management of chronic hepatitis B virus infection. J. Hepatol. 2012; 57: 167-185.
17. Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology 2009; 50: 661-662.
18. Yeh SH, Tsai CY, Kao JH etal. Quantification and genotyping of hepatitis B virus in a single reaction by real-time PCR and melting curve analysis. J. Hepatol. 2004; 41: 659-666.
19. Liu SF, Hsieh MH, Hou NJ etal. Hepatitis B virus genotyping by enzyme-linked immunosorbent assay in Taiwan. Hepatol. Int. 2010; 4: 601-607.
20. Tseng TC, Liu CJ, Su TH etal. Young chronic hepatitis B patients with nucleos(t)ide analogue-induced hepatitis B e antigen seroconversion have a higher risk of HBV reactivation. J. Infect. Dis. 2012; 206: 1521-1531.
21. Su TH, Hsu CS, Chen CL etal. Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B. Antivir. Ther. 2010; 15: 1133-1139.
22. Su TH, Liu CJ, Tseng TC etal. Longitudinal change of HBsAg in HBeAg-negative patients with genotype B or C infection. PLoS ONE 2013; 8: e55916.
23. Tseng TC, Liu CJ, Yang HC etal. Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load. Hepatology 2012; 55: 68-76.
24. Tseng TC, Liu CJ, Chen CL etal. Risk stratification of hepatocellular carcinoma in hepatitis B virus e antigen-negative carriers by combining viral biomarkers. J. Infect. Dis. 2013; 208: 584-593.
25. Brunetto MR, Oliveri F, Colombatto P etal. Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers. Gastroenterology 2010; 139: 483-490.
26. Reijnders JG, Perquin MJ, Zhang N, Hansen BE, Janssen HL. Nucleos(t)ide analogues only induce temporary hepatitis B e antigen seroconversion in most patients with chronic hepatitis B. Gastroenterology 2010; 139: 491-498.
27. Chen CF, Lee WC, Yang HI etal. Changes in serum levels of HBV DNA and alanine aminotransferase determine risk for hepatocellular carcinoma. Gastroenterology 2011; 141: 1240-1248, 8 e1-2.